CompositionEptus 25 Tablet is used to manage hypertension and to reduce the risk of heart failure in patients with reduced ventricular function, particularly following a myocardial infarction. It contains eplerenone, an aldosterone receptor antagonist. It works by blocking the effects of aldosterone, a hormone that increases salt and water retention. This action reduces fluid buildup, lowers blood pressure, and decreases the workload on the heart. It is particularly beneficial for heart failure patients and helps maintain proper potassium levels in the bloodstream while removing excess water from the body.
After oral administration, Eptus 25 Tablet is rapidly absorbed and reaches maximum plasma concentrations within 1-2 hours. It is metabolised in the liver and excreted mainly in the faeces, helping maintain the body’s fluid balance and support cardiovascular health.
Eptus 25 Tablet can also cause dizziness or lightheadedness, especially during the initial days of treatment. Therefore, patients should follow their healthcare provider's instructions for taking the medication and promptly report any side effects or concerns. However, this tablet has been shown to improve heart function and reduce hospitalisations for heart failure in these patients.
